Publications 2018 [References 927– 962]

927.   Attwell K, Ward PR, Meyer SB, Rokkas PJ, Leask J. "Do-it-yourself": vaccine rejection and complementary and alternative medicine (CAM). Social Science and Medicine 2018;196:106-14. [Full text]

928.   Gidding HF, Quinn HE, Hueston L, Dwyer DE, McIntyre PB. Declining measles antibodies in the era of elimination: Australia's experience. Vaccine 2018;36:507-13. [Abstract]

929.   King CL, Leask J. Parental disease prevention health beliefs and triggers for keeping children home from childcare – a qualitative study in Sydney, Australia. Child: Care, Health and Development 2018;44:326-31. [Abstract]

930.   Badahdah AM, Khatami A, Tashani M, Rashid H, Booy R. Evidence for rise in meningococcal serogroup C bactericidal antibody titers in the absence of booster vaccination in previously vaccinated children. Pediatric Infectious Disease Journal 2018;37:e66-71. [Abstract]

931.   Chen C, Wood JG, Beutels P, Menzies R, MacIntyre CR, Dirmesropian S, Reyes JF, McIntyre P, Newall AT. The role of timeliness in the cost-effectiveness of older adult vaccination: a case study of pneumococcal conjugate vaccine in Australia. Vaccine 2018;36:1265-71. [Abstract]

932.   Saul N, Wang K, Bag S, Baldwin H, Alexander K, Chandra M, Thomas J, Quinn H, Sheppeard V, Conaty S. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW Public Health Network case-control study. Vaccine 2018;36:1887-92. [Abstract]

933.   Alfelali M, Barasheed O, Badahdah AM, Bokhary H, Azeem MI, Habeebullah T, Bakarman M, Asghar A, Booy R, Rashid H. Influenza vaccination among Saudi Hajj pilgrims: revealing the uptake and vaccination barriers. Vaccine 2018;36:2112-18. [Abstract]

934.   Novakovic D, Cheng AT, Zurynski Y, Booy R, Walker PJ, Berkowitz R, Harrison H, Black R, Perry C, Vijayasekaran S, Wabnitz D, Burns H, Tabrizi SN, Garland SM, Elliott E, Brotherton JM. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. Journal of Infectious Diseases 2018;217:208-12. [Abstract]

935.   Edirisuriya C, Beard FH, Hendry AJ, Dey A, Gidding HF, Hueston L, Dwyer DE, Wood JG, Macartney KK, McIntyre PB. Australian rubella serosurvey 2012–2013: nn track for elimination? Vaccine 2018;36:2794-8. [Abstract]

936.   Thomas S, Cashman P, Islam F, Baker L, Clark K, Leask J, Butler R, Durrheim DN. Tailoring immunisation service delivery in a disadvantaged community in Australia: views of health providers and parents. Vaccine 2018;36:2596-603. [Abstract]

937.   Britton PN, Jones CA, Macartney K, Cheng AC. Parechovirus: an important emerging infection in young infants. Medical Journal of Australia 2018;208:365-9. [Abstract]

938.   Whittaker E, Goldblatt D, McIntyre P, Levy O. Neonatal immunization: rationale, current state, and future prospects. Frontiers of Immunology 2018;9:532. [Full text]

939.   Costa-Pinto JC, Willaby HW, Leask J, Hoq M, Schuster T, Ghazarian A, O'Keefe J, Danchin MH. Parental Immunisation Needs and Attitudes Survey in paediatric hospital clinics and community maternal and child health centres in Melbourne, Australia. Journal of Paediatrics and Child Health 2018;54:522-9. [Abstract]

940.   Lee VY, Booy R, Skinner R, Edwards KM. The effect of exercise on vaccine-related pain, anxiety and fear during HPV vaccinations in adolescents. Vaccine 2018;36:3254-9. [Abstract]

941.   Macartney K, Gershon AA. Shingles vaccine after auto-HSCT decreases risk [comment]. The Lancet 2018;391:2082-4. [No abstract available]

942.   Cheah BC, Davies J, Singh GR, Wood N, Jackson K, Littlejohn M, Davison B, McIntyre P, Locarnini S, Davis JS, Tong SY. Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia. Vaccine 2018;36:3533-40. [Abstract]

943.   Moore HC, Fathima P, Gidding HF, de Klerk N, Liu B, Sheppeard V, Effler PV, Snelling TL, McIntyre P, Blyth CC. Assessment of on-time vaccination coverage in population subgroups: a record linkage cohort study. Vaccine 2018;36:4062-9. [Abstract]

944.   Sellens E, Norris JM, Dhand NK, Heller J, Hayes L, Gidding HF, Willaby H, Wood N, Bosward KL. Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: implications for workplace health and safety compliance. PLoS One 2018;13:e0198421. [Full text]

945.   Hendry AJ, Beard FH, Dey A, Meijer D, Campbell-Lloyd S, Clark KK, Hull BP, Sheppeard V. Closing the vaccination coverage gap in New South Wales: the Aboriginal Immunisation Healthcare Worker Program. Medical Journal of Australia 2018;209:24-8. [Full text]

946.   King CL, Chow MYK, Wiley KE, Leask J. Much ado about flu: a mixed methods study of parental perceptions, trust and information seeking in a pandemic. Influenza and Other Respiratory Viruses 2018;12:514-21. [Full text]

947.   Dyda A, McIntyre P, Karki S, MacIntyre CR, Newall AT, Banks E, Kaldor J, Liu B. Pertussis vaccination in a cohort of older Australian adults following a cocooning vaccination program. Vaccine 2018;36:4157-60. [Abstract]

948.   Whitford K, Liu B, Micallef J, Yin JK, Macartney K, Van Damme P, Kaldor JM. Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis. Bulletin of the World Health Organization 2018;96:484-97. [Full text]

949.   Alexander KE, Tong PL, Macartney K, Beresford R, Sheppeard V, Gupta M. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection. Vaccine 2018;36:3890-3. [Abstract]

950.   Phillips A, Patel C, Pillsbury A, Brotherton J, Macartney K. Safety of human papillomavirus vaccines: an updated review. Drug Safety 2018;41:329-46. [Abstract]

951.   Phillips A, Beard F, Macartney K, Chan J, Gilmour R, Saravanos G, McIntyre P. Vaccine-preventable child deaths in New South Wales from 2005 to 2014: how much is preventable? Journal of Paediatrics and Child Health 2018;54:356-64. [Abstract]

952.   Macartney K, Phillips A, Patel C, Pillsbury A, Brotherton J. Authors' reply: Safety of human papillomavirus vaccines [letter]. Drug Safety 2018;41:541-3. [No abstract available]

953.   Gidding HF, McCallum L, Fathima P, Moore HC, Snelling TL, Blyth CC, Jayasinghe S, Giele C, de Klerk N, Andrews RM, McIntyre PB. Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia. Vaccine 2018;36:2650-6. [Abstract]

954.   Kaufman J, Ryan R, Walsh L, Horey D, Leask J, Robinson P, Hill S. Face-to-face interventions for informing or educating parents about early childhood vaccination. Cochrane Database of Systematic Reviews 2018;(5):CD010038. [Full text]

955.   Tashani M, Alfelali M, Barasheed O, Alqahtani AS, Heron L, Wong M, Rashid H, Findlow H, Borrow R, Booy R. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: a randomised controlled trial. Vaccine 2018;36:4375-82. [Abstract]

956.   Jayasinghe S, Chiu C, Quinn H, Menzies R, Gilmour R, McIntyre P. Effectiveness of 7- and 13-valent pneumococcal conjugate vaccines in a schedule without a booster dose: a 10-year observational study. Clinical Infectious Diseases 2018;67:367-74. [Abstract]

957.   Sheel M, Kirk MD. Parasitic and parachute research in global health [letter]. The Lancet Global Health 2018;6:e839. [Full text]

958.   Bedford H, Attwell K, Danchin M, Marshall H, Corben P, Leask J. Vaccine hesitancy, refusal and access barriers: the need for clarity in terminology. Vaccine 2017; August: [Epub ahead of print] doi:10.1016/j.vaccine.2017.08.004. [Abstract]

959.   Danchin MH, Costa-Pinto J, Attwell K, Willaby H, Wiley K, Hoq M, Leask J, Perrett KP, O'Keefe J, Giles ML, Marshall H. Vaccine decision-making begins in pregnancy: correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake. Vaccine 2017; August: [Epub ahead of print] doi:10.1016/j.vaccine.2017.08.003. [Abstract]

960.   Berry NJ, Danchin M, Trevena L, Witteman HO, Kinnersley P, Snelling T, Robinson P, Leask J. Sharing Knowledge About Immunisation (SKAI): an exploration of parents' communication needs to inform development of a clinical communication support intervention. Vaccine 2018; January: [Epub ahead of print] doi:10.1016/j.vaccine.2017.10.077. [Abstract]

961.   Li-Kim-Moy J, Wood N, Jones C, Macartney K, Booy R. Impact of fever and antipyretic use on influenza vaccine immune reponses in children. Pediatric Infectious Disease Journal 2018; February: [Epub ahead of print] doi:10.1097/inf.0000000000001949. [Abstract]

962.   Sheridan SL, Patel C, Macartney K, Cheng AC. New enhanced influenza vaccines for older Australians: what promise do they hold? Medical Journal of Australia 2018; July: [Epub ahead of print] doi:10.5694/mja18.00334. [Full text]

Papers in press

Wood N, Marshall H, Nolan T, McIntyre P, Richmond P, Perrett K, Gibbs EA. Immunogenicity and safety of monovalent acellular pertussis vaccine at birth: a randomized clinical trial. JAMA Pediatrics

McHugh L, Marshall HS, Perrett KP, Nolan T, Wood N, Lambert SB, Richmond P, Ware RS, Binks P, Binks MJ, Andrews RM. The safety of influenza and pertussis vaccination in pregnancy in a cohort of Australian mother-infant pairs, 2012-2015: the FluMum study. Clinical Infectious Diseases






Last updated 21 July 2018